Stockreport

IDEAYA's rare cancer drug shows promise as company lays out Phase III plans [Yahoo! Finance]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF Darovasertib, a protein kinase inhibitor C (PKC) being evaluated in neoadjuvant uveal melanoma (UM), has achieved a tumour shrinkage of at least 30% in around half of p [Read more]